Keratinocyte growth factor (KGF; palifermin or repifermin), intravenous vs placebo
Interruptions to cancer treatment (chemotherapy delays/discontinuations) · Adults with cancer receiving treatment
Keratinocyte growth factor (KGF; palifermin or repifermin),… showed no clear difference in interruptions to cancer treatment (chemotherapy… compared with placebo; GRADE not reported.
1 finding from 1 review
- Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors 2017 · Cochrane All outcomesRT to head and neck with cisplatin/fluorouracilRR 0.96 [0.62, 1.47]2 studies · 374 participantsGRADE not reported